Structured Knowledge Management Platform for Bioprocess Development

August 4, 2025

Bioprocess development for producing biotherapeutics at quality and scale is undergoing dynamic workflow shifts. The adoption of laboratory automation, high-throughput processes, and process analytical technologies (PAT) has led to an exponential increase in the volume of data to be captured, parsed, and analyzed. To address these complexities, we introduce an end-to-end data management and workflow support platform capable of registering and interpreting a wide range of biologic modalities including proteins (e.g., IgGs, ADCs, bispecifics, enzymes), RNA and DNA therapeutics and vaccines (e.g., mRNA, DNA vaccines, ASOs), and cell and gene therapeutics (e.g., AAVs, CAR-T cells). Developed in close collaboration with leading biopharmaceutical and biotech organizations, the platform was designed to understand real-world data workflow needs. It automates cell line development from clone selection to characterization and reporting, facilitates the evaluation of numerous small-scale upstream processes (USP), manages USP and scale-up, supports downstream process (DSP) development, and facilities analytical and formulation workflows. Acting as a single source of truth, it tracks the lineage of every intermediate and batch, along with all analytical and process data, raw materials used, equipment details, and molecule and cell line information. With full, end-to-end capture and traceability of every segment of the scale up process, the platform enhances process and product understanding while strengthening quality risk management. Additionally, the structured data foundation ensures seamless integration and readiness for AI/ML tools, supporting predictive modeling, digital twins, and data-driven innovation in biotherapeutic development.